Undervalued Small Caps With Insider Buying

Results

195

32 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

195 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AUBN
US$26.26-0.1%-2.4%US$91.5mn/a1.0n/a4.1%Banks
ORN
New
US$10.3313.8%45.1%US$412.2mUS$15.32116.174.8%n/aCapital Goods
UNB
US$23.781.1%-9.4%US$108.4mn/a1.2n/a6.1%Banks
EW
₱11.66-1.0%-8.9%₱26.2b₱13.700.38.8%5.8%Banks
PGC
AU$0.134.0%-66.7%AU$215.2mAU$0.250.196.0%n/aHealthcare
BCI
AU$0.454.7%25.4%AU$1.3bAU$0.63342.047.6%0%Materials
OU8
S$1.646.5%-9.4%S$1.4bS$1.8812.0-0.3%2.4%Real Estate Management and Development
OCE
R71.50-0.6%34.6%R8.5bR90.0012.08.3%4.0%Food, Beverage & Tobacco
1837
HK$1.611.6%103.2%HK$3.5bHK$2.1611.417.9%4.4%Food, Beverage & Tobacco
AVIA
Rp326.002.5%-24.2%Rp19.3tRp519.0010.75.9%6.7%Materials
SECB
₱68.301.7%-10.5%₱51.5b₱96.920.314.7%4.4%Banks
NOHO
€8.076.7%-8.3%€170.2m€8.8016.218.0%2.9%Consumer Services
BMRC
US$28.730.1%31.4%US$465.8mUS$31.801.2102.5%3.5%Banks
BILI A
SEK 152.00-2.0%28.9%SEK 14.1bSEK 165.6716.515.4%3.9%Retail
RCEL
US$4.755.8%-11.7%US$137.6mUS$9.072.064.1%n/aPharmaceuticals & Biotech
KINS
US$19.03-4.7%26.3%US$301.3mUS$21.507.816.7%1.1%Insurance
PMZ.UN
CA$22.29-2.7%50.2%CA$2.6bCA$25.501.031.9%3.9%Real Estate
QUEST
€7.241.1%-4.5%€766.0mn/a15.513.3%5.5%Tech
JOMA
New
SEK 58.50-2.0%-5.6%SEK 4.3bSEK 67.008.1-44.4%0.4%Real Estate Management and Development
ENOV
New
US$26.61-8.7%-6.4%US$1.5bUS$41.250.7137.6%n/aHealthcare
PZA
CA$12.942.6%-20.2%CA$437.4mCA$12.0014.339.9%7.2%Consumer Services
NXR.UN
CA$7.93-3.3%1.9%CA$782.5mCA$8.500.53.0%8.1%Real Estate
SHBI
US$24.11-1.4%58.8%US$813.3mUS$25.751.38.1%2.3%Banks
ILPT
US$8.611.7%51.1%US$584.0mUS$10.831.224.0%4.6%Real Estate
Page 1 of 6